AMARIN CORP PLC\UK Cash and Cash Equivalents, Period Increase (Decrease)
AMARIN CORP PLC\UK (AMRN) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$24.61 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-27
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$5.45M.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$6.38M, a 114.15% decline year-over-year.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$10.61M.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$2.17M.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$24.61M.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$8.71M.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$12.58M.
- AMARIN CORP PLC\UK cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$71.97M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$11.83M derived: sum of 2 quarters · filed 2018-02-27 | -$22.44M derived: sum of 3 quarters · filed 2018-02-27 | -$24.61M 10-K · filed 2018-02-27 |
| 2017-09-30 | -$6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$16.99M derived: sum of 2 quarters · filed 2017-11-01 | -$19.16M 10-Q · filed 2017-11-01 | -$38.48M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | -$10.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$12.79M 10-Q · filed 2017-08-02 | -$32.10M derived: sum of 3 quarters · filed 2018-02-27 | $12.97M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-03-31 | -$2.17M 10-Q · filed 2017-05-03 | -$21.49M derived: sum of 2 quarters · filed 2018-02-27 | $23.59M derived: sum of 3 quarters · filed 2018-02-27 | $14.71M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | -$19.31M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $25.76M derived: sum of 2 quarters · filed 2018-02-27 | $16.89M derived: sum of 3 quarters · filed 2018-02-27 | -$8.71M 10-K · filed 2018-02-27 |
| 2016-09-30 | $45.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $36.20M derived: sum of 2 quarters · filed 2017-11-01 | $10.60M 10-Q · filed 2017-11-01 | -$1.41M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$8.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$34.47M 10-Q · filed 2017-08-02 | -$46.48M derived: sum of 3 quarters · filed 2018-02-27 | -$63.56M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$25.60M 10-Q · filed 2017-05-03 | -$37.61M derived: sum of 2 quarters · filed 2018-02-27 | -$54.69M derived: sum of 3 quarters · filed 2018-02-27 | -$79.83M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$12.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$29.09M derived: sum of 2 quarters · filed 2018-02-27 | -$54.23M derived: sum of 3 quarters · filed 2018-02-27 | -$12.58M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$17.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$42.22M derived: sum of 2 quarters · filed 2016-11-03 | -$563.00K 10-Q · filed 2016-11-03 | -$16.46M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$25.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $16.51M 10-Q · filed 2016-08-04 | $615.00K derived: sum of 3 quarters · filed 2017-03-01 | -$14.48M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $41.66M 10-Q · filed 2016-05-05 | $25.76M derived: sum of 2 quarters · filed 2017-03-01 | $10.67M derived: sum of 3 quarters · filed 2017-03-01 | -$3.08M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$30.99M derived: sum of 2 quarters · filed 2017-03-01 | -$44.74M derived: sum of 3 quarters · filed 2017-03-01 | -$71.97M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$15.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$28.84M derived: sum of 2 quarters · filed 2015-11-04 | -$56.08M 10-Q · filed 2015-11-04 | -$90.45M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$13.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$40.99M 10-Q · filed 2015-08-06 | -$75.36M derived: sum of 3 quarters · filed 2016-02-25 | $1.10M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$27.24M 10-Q · filed 2015-05-08 | -$61.61M derived: sum of 2 quarters · filed 2016-02-25 | $14.85M derived: sum of 3 quarters · filed 2016-02-25 | -$37.50M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$34.37M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $42.09M derived: sum of 2 quarters · filed 2016-02-25 | -$10.27M derived: sum of 3 quarters · filed 2016-02-25 | -$68.73M 10-K · filed 2016-02-25 |
| 2013-09-30 | $76.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $24.11M derived: sum of 2 quarters · filed 2014-11-06 | -$34.36M 10-Q · filed 2014-11-06 | $10.78M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | -$52.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$110.82M 10-Q · filed 2014-08-07 | -$65.68M derived: sum of 3 quarters · filed 2015-03-03 | -$100.83M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | -$58.46M 10-Q · filed 2014-05-09 | -$13.33M derived: sum of 2 quarters · filed 2015-03-03 | -$48.48M derived: sum of 3 quarters · filed 2015-03-03 | -$44.04M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $45.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $9.99M derived: sum of 2 quarters · filed 2015-03-03 | $14.42M derived: sum of 3 quarters · filed 2015-03-03 | $143.64M 10-K · filed 2015-03-03 |
| 2012-09-30 | -$35.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$30.71M derived: sum of 2 quarters · filed 2013-11-07 | $98.51M 10-Q · filed 2013-11-07 | $89.25M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $133.65M 10-Q · filed 2013-08-08 | $124.40M derived: sum of 3 quarters · filed 2014-02-27 | $118.81M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $129.22M 10-Q · filed 2013-05-09 | $119.97M derived: sum of 2 quarters · filed 2014-02-27 | $114.38M derived: sum of 3 quarters · filed 2014-02-27 | $116.34M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$9.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$14.84M derived: sum of 2 quarters · filed 2014-02-27 | -$12.88M derived: sum of 3 quarters · filed 2014-02-27 | $85.16M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$3.63M derived: sum of 2 quarters · filed 2012-11-08 | $94.41M 10-Q · filed 2012-11-08 | $94.37M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $100.00M 10-Q · filed 2012-08-08 | $99.96M derived: sum of 3 quarters · filed 2013-02-28 | $93.70M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $98.04M 10-Q · filed 2012-05-08 | $98.00M derived: sum of 2 quarters · filed 2013-02-28 | $91.74M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$6.30M derived: sum of 2 quarters · filed 2013-02-28 | -$20.82M 10-K · filed 2013-02-28 | |
| 2010-09-30 | -$6.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$20.77M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$14.51M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $38.02M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |